[Federal Register: September 5, 2008 (Volume 73, Number 173)]
[Notices]
[Page 51830-51831]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05se08-60]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2008-N-0450]
Science Board to the Food and Drug Administration; Request for
NominationsSUBJECT>
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is requesting nominations to
serve on the Science Board to the FDA (Science Board).
[[Page 51831]]
FDA has special interest in ensuring that women, minority groups,
and individuals with disabilities are adequately represented on
advisory committees and, therefore, encourages nominations qualified
candidates from these groups.
DATES: Nominations received on or before October 6, 2008 will be given
first consideration for membership on the Science Board. Nominations
received after October 6, 2008 will be considered for nomination to the
Science Board should nominees still be needed.
ADDRESSES: All nomination for membership should be sent electronically
to CV@OC.FDA.GOV, or by mail to Advisory Committee Oversight &
Management Staff, 5600 Fishers Lane (HF-4), rm. 15A-12, Rockville, MD
20857.
FOR FURTHER INFORMATION CONTACT: Regarding all nomination questions for
membership, the primary contact is Carlos Pe[ntilde]a, Office of
Science and Health Coordination, Office of the Commissioner, Food and
Drug Administration (HF-33), 5600 Fishers Lane, Rockville, MD 20857,
301-827-6687, e-mail: carlos.Pe[ntilde]a@fda.hhs.gov. Information about
becoming a member on a FDA advisory committee can also be obtained by
visiting FDA's Web site by using the following link http://www.fda.gov/
oc/advisory/default.htm.
SUPPLEMENTARY INFORMATION: FDA is requesting nominations to the Science
Board. The Science Board will meet approximately four times a year.
Meetings of the Science Board will be open to the public. All meetings
will be announced in the Federal Register at least 15 days prior to
each scheduled public meeting.
I. General Function of the Committee
The Science Board shall provide advice primarily to the
Commissioner and other appropriate officials on specific complex and
technical issues as well as emerging issues within the scientific
community. Additionally, the Science Board will provide advice to the
Agency on keeping pace with technical and scientific evolutions in the
fields of regulatory science; on formulating an appropriate research
agenda; and on upgrading its scientific and research facilities to keep
pace with these changes. It will also provide the means for critical
review of Agency sponsored intramural and extramural scientific
research programs.
II. Criteria for Members
Persons nominated for membership shall be knowledgeable in the
fields of food safety, nutrition, chemistry, pharmacology, toxicology,
clinical research, or other scientific disciplines such as systems
biology, wireless healthcare devices, nanotechnology, medical imaging,
robotics, cell and tissue based products, regenerative medicine, and
combination products. Members shall be chosen from academia and
industry. The Science Board may include one technically qualified
member, selected by the Commissioner or designee, who is identified
with consumer interests and is recommended by either a consortium of
consumer-oriented organizations or other interested persons. The
Science Board may also include technically qualified Federal members.
III. Nomination Procedures
Any interested person may nominate one or more qualified person for
membership on the Science Board. Self nominations are also accepted.
Nominations shall include the name of the committee, complete
curriculum vitae of each nominee, and their current business address
and telephone number and e-mail address if available. Each nomination
shall state that the nominee is aware of the nomination, is willing to
serve as a member, and appears to have no conflict of interest that
would preclude membership. FDA will ask the potential candidates to
provide detailed information concerning such matters as financial
holdings, employment, and research grants and/or contracts to permit
evaluation of possible sources of conflict of interest.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14 relating to advisory committees.
Dated: August 27, 2008.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E8-20574 Filed 9-4-08; 8:45 am]
BILLING CODE 4160-01-S